Pharmaceutical Adulteration

Pharmaceutical Adulteration is the intentional addition of undeclared pharmaceutical substances to dietary supplements, distinguishing it from other forms of contamination by involving deliberate, covert formulation practices that pose significant toxicity risks to consumers.

55

Publications

2.7K

Citations

227

Authors

90

Institutions

Publications per year

2017–2026

18

Authors

227

  1. YL
    Yung‐Chuan Liu

    National Chung Hsing University, Taiwan

    4 publications · 70 citations

    4

    h-index

  2. ML
    Mei-Chih Lin

    Taiwan Food and Drug Administration, Taiwan

    3 publications · 43 citations

    3

    h-index

  3. TW
    Tony W.L. Mak

    Hospital Authority, Hong Kong SAR China

    3 publications · 138 citations

    3

    h-index

  4. SW
    Sau Wah Ng

    Hospital Authority, Hong Kong SAR China

    3 publications · 128 citations

    3

    h-index

  5. AY
    Albert Y W Chan

    Hospital Authority, Hong Kong SAR China

    2 publications · 85 citations

    2

    h-index

1–5 of 227

Venues

  1. 5

    h-index

  2. Journal of Food and Drug Analysis

    5 publications · 96 citations

    5

    h-index

  3. PubMed

    Repository · 3 publications · 126 citations

    3

    h-index

  4. Regulatory Toxicology and Pharmacology

    RTP · 2 publications · 123 citations

    2

    h-index

  5. Food Additives & Contaminants Part A

    2 publications · 63 citations

    2

    h-index

1–5